Relentless pursuit of innovation
ApiSyn Healthcare was established in March 2020 as a vertically integrated API and intermediate manufacturing company. ApiSyn bold mission has been to master complex chemistry with precision and achieve the fastest scale-up from Research to Reality.
Learn More About Us →
High-quality Active Pharmaceutical Ingredients for global markets
Built on Quality, Compliance & Reliable API Manufacturing
Every batch is manufactured under robust quality systems with stringent QA/QC controls and advanced analytical capabilities.
Comprehensive regulatory and technical documentation including DMF, CEP, COA, stability data, validation reports, and customer-specific dossiers.
WHO-GMP aligned manufacturing systems designed to support customer audits and meet regulated market expectations with confidence.
Integrated manufacturing capacity with disciplined planning and consistent execution to ensure dependable and on-time supply.
Strong R&D and process chemistry expertise, robust analytical methods, impurity control, and scale-up from development to commercialization.
Dedicated support across technical, regulatory, and commercial functions to accelerate your development and ensure long-term success.
Products and Services
Driven by a relentless pursuit of innovation, our extensive research and development infrastructure, alongside our dedicated workforce, delivering wide range of chemistry solutions in custom synthesis, process research, and manufacturing to various pharmaceutical companies globally.
Our state-of-the-art manufacturing facility in Ahmedabad features multi-purpose reactors, dedicated cleanrooms, and advanced analytical laboratories — all designed for multi-ton commercial API, Low volume API and Peptides under strict cGMP conditions.
Our Commitment to Quality and Compliance
APIs, Advance Intermediates, Custom Peptides, Amino acids or CDMO Services - Our team is ready to support your requirements with High Quality and Competitive Pricing.
Subscribe to receive updates on new API launches and regulatory filings.